Pathogenesis and clinical translation of intrahepatic cholangiocarcinoma in the era of precision medicine
DOI:10.3969/j.issn.1001-5256.2021.04.045
- VernacularTitle:精准医学时代下肝内胆管癌的发病机制与临床转化
- Author:
Wenhua YOU
1
;
Yuan LIANG
;
Ling LYU
Author Information
1. School of Biomedical Engineering and Informatics, Nanjing Medical University, Nanjing 211166, China
- Publication Type:Research Article
- Keywords:
Cholangiocarcinoma;
Tumor Microenvironment;
Diagnosis;
Therapeutics
- From:
Journal of Clinical Hepatology
2021;37(4):935-938
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma (ICC) is an important liver malignancy next only to hepatocellular carcinoma, accounting for 15%-20% of primary liver cancer. In recent years, the incidence rate of ICC tends to increase globally; however, due to its insidious onset, high degree of malignancy, and strong invasive ability, most patients are in the advanced stage when attending the hospital and thus miss the most appropriate timing for surgery. With the continuous development of next-generation sequencing, the treatment of ICC gradually develops towards the direction of individualization and precision. This article introduces the basic research advances in the pathogenesis, molecular typing, and early diagnosis of ICC and reviews the clinical translational research of ICC in recent years, so as to provide new ideas for the treatment and clinical research of ICC.
